Yang S, Li N, Zhu R, Feng Y, et al. Impacts of early therapy response, interval to therapy interruption, and cumulative therapy interruption duration on outcome of ibrutinib therapy in relapsed/refractory chronic lymphocytic leukemia. Ann Hematol 2023 Jul 1. doi: 10.1007/s00277-023-05309.
PMID: 37393401